Novartis Oncology Universal Co-pay Program: Adakveo

Funded
About
The Novartis Oncology Universal Co-pay Program: Adakveo provides substantial financial relief for patients prescribed Adakveo. With this program, commercially insured patients pay no more than $25 per month, with an annual benefit of up to $15,000. The program is designed for U.S. and Puerto Rico patients with private insurance, offering an automatic renewal process for continued support year after year. The Novartis Oncology Universal Co-pay Program: Adakveo ensures patients have manageable costs, facilitating access to their needed medication.
Insurance requirements: Commercially insured
As low as: $25 per mo
Enrollment Forms
Enrollment Form
Benefits
•12 maximum fills per year
Program Requirements
•Valid only for residents in the US and Puerto Rico
•Enrollment Required: Yes
•Coverage Required: No
•Needs Based: No
•Activation Required: No
Program Details
•Commercially insured patients pay no more than $25 per month; program pays up to $15,000 per calendar year
•Card can be printed for immediate use following online eligibility questions and registration
•Offer may not be combined with any other rebate, coupon, or other offer(s)
•Patient automatically reenrolled on the 1st of each calendar year if commercial insurance remains active and covers drug (Novartis copay cards DO NOT EXPIRE)